rs1018854

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000845.3(GRM8):​c.727+89005C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 151,804 control chromosomes in the GnomAD database, including 19,750 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 19750 hom., cov: 32)

Consequence

GRM8
NM_000845.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.657

Publications

4 publications found
Variant links:
Genes affected
GRM8 (HGNC:4600): (glutamate metabotropic receptor 8) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000845.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.532 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000845.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM8
NM_000845.3
MANE Select
c.727+89005C>T
intron
N/ANP_000836.2O00222-1
GRM8
NM_001371086.1
c.727+89005C>T
intron
N/ANP_001358015.1A0A9L9PYG5
GRM8
NM_001127323.1
c.727+89005C>T
intron
N/ANP_001120795.1O00222-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM8
ENST00000339582.7
TSL:5 MANE Select
c.727+89005C>T
intron
N/AENSP00000344173.2O00222-1
GRM8
ENST00000358373.8
TSL:1
c.727+89005C>T
intron
N/AENSP00000351142.3O00222-2
GRM8
ENST00000341617.7
TSL:1
n.727+89005C>T
intron
N/AENSP00000345747.3O00222-3

Frequencies

GnomAD3 genomes
AF:
0.507
AC:
76956
AN:
151688
Hom.:
19709
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.537
Gnomad AMI
AF:
0.444
Gnomad AMR
AF:
0.477
Gnomad ASJ
AF:
0.647
Gnomad EAS
AF:
0.346
Gnomad SAS
AF:
0.492
Gnomad FIN
AF:
0.413
Gnomad MID
AF:
0.538
Gnomad NFE
AF:
0.517
Gnomad OTH
AF:
0.537
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.508
AC:
77055
AN:
151804
Hom.:
19750
Cov.:
32
AF XY:
0.501
AC XY:
37158
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.537
AC:
22260
AN:
41420
American (AMR)
AF:
0.477
AC:
7260
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.647
AC:
2243
AN:
3468
East Asian (EAS)
AF:
0.346
AC:
1773
AN:
5128
South Asian (SAS)
AF:
0.493
AC:
2376
AN:
4818
European-Finnish (FIN)
AF:
0.413
AC:
4350
AN:
10538
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.517
AC:
35102
AN:
67900
Other (OTH)
AF:
0.539
AC:
1135
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1978
3956
5933
7911
9889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
684
1368
2052
2736
3420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.515
Hom.:
86618
Bravo
AF:
0.514
Asia WGS
AF:
0.443
AC:
1538
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.2
DANN
Benign
0.36
PhyloP100
0.66
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1018854;
hg19: chr7-126657545;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.